Skip to main content
Serge Jabbour, MD, Endocrinology, Philadelphia, PA

SergeA.JabbourMD

Endocrinology Philadelphia, PA

Diabetes, Lipid Metabolism

Director, Division of Endocrinology, Professor of Medicine, Thomas Jefferson University

Dr. Jabbour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jabbour's full profile

Already have an account?

  • Office

    211 S 9th St, Ste 600
    Philadelphia, PA 19107
    Phone+1 215-955-1925
    Fax+1 215-928-3160

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1994 - 1997
  • St Joseph's University Medical School
    St Joseph's University Medical SchoolClass of 1993
  • La Sagesse College
    La Sagesse CollegeBachelors, Experimental Sciences, 1983 - 1986

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1997 - 2024
  • FL State Medical License
    FL State Medical License 2021 - 2023
  • NJ State Medical License
    NJ State Medical License 1999 - 2003
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Philadelphia Magazine Castle Connolly, 2011-2015
  • Top Doctor in Endocrinology South Jersey Magazine, 2013
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety and Efficacy of Exenatide Once Weekly plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients with Type 2 Diabetes Inadequately Contro...  
    Serge Jabbour, MD, Diabetes Care
  • An Open Label Randomized Phase II Study of Pasireotide With or Without Everolimus in Castrate-Resistant Chemotherapy-Naïve Prostate Cancer Patients  
    Lin J, Deng A, Hoffman-Censits J, Gibney G, Hyslop T, Miller B, Kilpatrick D, Jabbour S, Kelly WK, Cancer Treatment Communications, 1/1/2015
  • Incidence and Severity of Pancreatogenic Diabetes after Pancreatic Resection  
    Burkhart RA, Gerber SM, Tholey RM, Lamb KM, Somasundaram A, McIntyre CA, Fradkin EC, Ashok AP, Felte RF, Mehta JM, Rosato EL, Lavu H, Jabbour SA, Yeo CJ, and Winter JM, Journal of Gastrointestinal Surgery, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Robust Dose-dependent Glucose Lowering and Body Weight (BW) Reductions with the Novel Oral Formulation of Semaglutide in Patients with early Type 2 Diabetes (T2D)
    Jabbour S, Pieber T, Rosenstock J, Hartoft-Nielsen ML, Højbjerg Hansen OK, Davies M, The Endocrine Society, Boston, MA, 1/1/2016
  • Patient characteristics and real world effectiveness of dapagliflozin; an observational analysis of US electronic health records
    Jabbour S, Bell K, Eudicone J, Shatskov A, Katz A, WCIR, 13th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease, Los Angeles, CA, 1/1/2015
  • Incidence of Radioiodine-induced Gastritis and the Dosage of I-131 Ablation for Differentiated Thyroid Cancer: Results of a Multi-year Analysis
    Intenzo C, Jabbour SA, Miller J, Kim S, Furlong K, Ahmed I, SNMMI (Society of Nuclear Medicine and Molecular Aging) Annual Meeting, Baltimore, MD, 1/1/2015
  • Join now to see all

Lectures

  • Guideline-Based Approach to Manage T2DM: Place of SGLT2-Inhibitors 
    Lucknow, India - 1/31/2015
  • Improving the Metabolic State in T2DM Patients & Associated Risks 
    Lucknow, India - 1/29/2015
  • Glucocorticoids and HPA Axis Suppression 
    Philadelphia, PA - 1/24/2015
  • Join now to see all

Other

Press Mentions

  • COVID-19 and Diabetes, What You Need to Know
    COVID-19 and Diabetes, What You Need to KnowOctober 29th, 2021
  • Combo Drug Treatment for Type 2 Diabetes Remains Effective After Two Years
    Combo Drug Treatment for Type 2 Diabetes Remains Effective After Two YearsNovember 2nd, 2020
  • Clinical Endocrinology Update Goes Bicoastal for a Second Year
    Clinical Endocrinology Update Goes Bicoastal for a Second YearJuly 30th, 2019
  • Join now to see all